- Peter Robins
Editorial and Content Manager, Drug Information, Pharma/Chem markets, Thomson Scientific
- Drug Information Editorial content and policy
(ie, IDdb and SDdb but also including to some extent Thomson Pharma Drug Content, ie MICROMEDEX, Newport Strategies)
- The drug R&D process from lead identification to launch
- The pharmaceutical industry in general, including strategy and key drivers
- Biotechnology, including biogenerics, and its impact on the pharmaceutical business model
- Emerging technologies such as pharmacogenomics
- Therapeutic taxonomies (ie, diseases and mechanisms of action)
Click here to contact
Back to main Experts page
|
|
